Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Acute Relapsing”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableStudy completedNCT04280484
What this trial is testing

Acute Intermittent Hypoxia in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Shirley Ryan AbilityLab 10
Large-scale testing (Phase 3)Study completedNCT01442233
What this trial is testing

Plasma Exchanges in Multiple Sclerosis (MS) Relapses

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Acute Relapsing
University Hospital, Bordeaux 38
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06223074
What this trial is testing

Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration

Who this might be right for
Multiple Sclerosis Relapsing RemittingTreatment
Universidad Nacional Autonoma de Mexico 80
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing

Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Galapagos NV 15
Early research (Phase 1)Study completedNCT02398461
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Who this might be right for
Multiple Sclerosis, Acute Relapsing
Acorda Therapeutics 27
Not applicableStudy completedNCT04546698
What this trial is testing

5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Acute RelapsingMultiple Sclerosis
Centre Hospitalier Régional d'Orléans 78
Post-approval studies (Phase 4)Ended earlyNCT01411514
What this trial is testing

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 27
Testing effectiveness (Phase 2)Study completedNCT00079495
What this trial is testing

Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Neurocrine Biosciences 150
Large-scale testing (Phase 3)Ended earlyNCT00947895
What this trial is testing

Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone

Who this might be right for
Multiple Sclerosis
Neurologique Foundation, Inc. 30
Not applicableUnknownNCT06280131
What this trial is testing

The Efficacy of Pulse Therapy in Acute Relapse in Multiple Sclerosis Patients:

Who this might be right for
Multiple Sclerosis
Assiut University 30
Large-scale testing (Phase 3)Ended earlyNCT00418145
What this trial is testing

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

Who this might be right for
Multiple Sclerosis
Fred Lublin 16
Early research (Phase 1)Study completedNCT01031199
What this trial is testing

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Who this might be right for
Positron-Emission TomographyMultiple Sclerosis
Bayer 16
Not applicableLooking for participantsNCT06390930
What this trial is testing

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab 22
Not applicableActive Not RecruitingNCT06413602
What this trial is testing

The Synergistic Effects of AIH and FES in Persons With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab 40
Not applicableActive Not RecruitingNCT05605782
What this trial is testing

A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb 9,000
Large-scale testing (Phase 3)Study completedNCT02290444
What this trial is testing

Effects of Acthar on Recovery From Cognitive Relapses in MS

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 64
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75